Evidence map›Paper›PMID 8329922›Full record

Trial reportBMJ (Clinical research ed.)1993

Uptake of cystic fibrosis testing in primary care: supply push or demand pull?

H Bekker, M Modell, G Denniss, A Silver, C Mathew, M Bobrow, T Marteau

Open access · bronzeAbstract readClinical TrialRandomized Controlled Trial
In one paragraph

Trial report in BMJ (Clinical research ed.), 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 6 pooled it
18.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 6 syntheses or guidelines pooled it, 199 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Increasing informed uptake and non-uptake of screening: evidence from a systematic review.Health expectations : an international journal of public participation in health care and health policy · 2001
    Pooled it
  6. Guideline
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. The evolving landscape of expanded carrier screening: challenges and opportunities.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Review
  12. Article
  13. Review
  14. Responsible implementation of expanded carrier screening.European journal of human genetics : EJHG · 2016
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

H BekkerWellcome Psychology and Genetics Research Group, United Medical School of Guy's Hospital, London.
M Modell
G Denniss
A Silver
C Mathew
M Bobrow
T Marteau
Guy's Hospital · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

objectiveTo determine the acceptability and feasibility of screening for carriers of cystic fibrosis in a primary care setting.

designFollow up study over 15 months of patients offered carrier testing by mouthwash.

settingA general practice in inner London. SUBJECTS: 5529 patients aged 18-45 invited by various methods and combinations of methods (letter, booklet, personal approach) for testing.

main outcome measuresUptake of screening, anxiety, and knowledge of test.

results957 (17%) invitees were screened over the 15 months. 28 carriers and no carrier couples were detected. Uptake rates were 12% (59/502 patients) among patients invited by letter and tested by appointment; 9% (47/496) among patients invited by letter, with leaflet, and tested by appointment; 4% (128/2953) among patients invited by letter six weeks before the end of the study and tested by appointment; 17% (81/471) among patients offered passive opportunistic testing; 70% (453/649) among patients offered active opportunistic testing; and 25% (22/88) among patients offered active opportunistic testing by appointment. A short term rise in anxiety among those given a positive test result had dissipated by three months. At three months about one fifth and one third of those given positive and negative results respectively did not understand their results correctly.

conclusionThese results suggest that the strongest variable in determining uptake of screening is the active approach by a health professional offering immediate testing. It remains to be resolved whether the high uptake rates achieved by active recruitment indicate a supply push for this new test rather than a demand from the population.

Indexed as

Primary Health CareAdolescentAdultAnxietyComprehensionCystic FibrosisFamily PracticeFeasibility StudiesFemaleGenetic Carrier ScreeningGenetic TestingHumansInformation DisseminationLondonMaleMiddle AgedMouthwashesEmpirical ApproachGenetics and ReproductionHealth Care and Public HealthNational Health Service

Identifiers

PMID8329922
PMCPMC1678014
OpenAlexW2104911676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.